ACCREDO HEALTH GROUP, INC.

ACCREDO

Business consulting services for proactive risk management, process improvement, performance measurement, and software projects;

ACCREDO HEALTH

Providing patient educational services, namely, conducting programs in the field of chronic disease, proper product-reconstitution and administration, and resources appropriate for support of disease management; educational services for product manufacturers, pharmaceutical clinicians and biotech companies, clinicians, contract research organizations and insurance providers, namely, conducting classes, one-on-one sessions and telephonic workshops in the field of clinical education and distributing course materials in connection therewith; educational services, namely, classes, one on one sessions and telephonic workshops which provide physicians, insurance companies and patients with specific characteristics associated with disease management products; educational services and resources, namely, conducting workshops for children to help them to understand hemophilia; educational services, namely, conducting workshops for children to help them understand hemophilia;Pharmaceutical preparations for the treatment of chronic diseases, namely, alpha-1 antitrypsin deficiency, moderate to severe persistent asthma, pulmonary arterial hypertension, respiratory syncytial virus, chronic, moderate to severe plaque psoriasis, hereditary tyrosinemia type 1, autoimmune disorders and primary immune deficiencies, growth hormone deficiency, Fabry disease, rheumatoid arthritis, psoriatic arthritis, hemophilia, Gaucher disease, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, multiple sclerosis, hypomobility associated with advanced Parkinson's disease, MPS 1, severe combined immunodeficiency disease, chronic granulomatour disease, severe malignant osterpetrosis; pharmaceutical preparations for use as blood clotting agents used in the control of hemophilia; pharmaceutical preparations for the treatment of chronic diseases, namely disorders requiring intravenous immunoglobulin therapy; pharmaceutical preparations for the treatment of hemophilia;Printed publications, namely, magazines featuring articles and information on blood disorders; newsletters and pamphlets featuring a series of stories on the subject of living with hemophilia; newsletters on the subject of hemophilia and related health issues;Providing information about government benefits and entitlements, and insurance, and related social services to people with chronic diseases and other health conditions;Retail pharmacy services specializing in the treatment and control of chronic diseases; retail pharmacy services specializing in the control of hemophilia;Providing patient advocate services to people with chronic diseases and other health conditions regarding government benefits and entitlements, and insurance, and related social services;Nursing care specializing in the treatment, prevention and control of chronic diseases; nursing care specializing in the treatment, prevention and control of hemophilia; medical services, namely, administration of pharmaceutical preparations used in the treatment of chronic diseases and administration of pharmaceutical preparations used in the treatment of hemophilia; administration of pharmaceutical preparations used in the treatment of chronic diseases; providing information concerning medical care and treatment in the field of hemophilia; disease management services; telephone hotline counseling, namely, offering healthcare advice regarding bleeding disorders; services consisting of providing nutritional guidance and consultation to chronically ill patients; medical services, namely, specialized pharmaceutical advice for individuals with bleeding disorders;HEALTH;Providing clinical research in the field of medicine for product manufacturers, pharmaceutical and biotech companies, contract research organizations and insurance providers, and providing consulting services in support of new drug product launches; medical services, namely, on-line analysis of infusion and bleeding activity for hemophiliacs;

ACCREDO HEALTH GROUP

Pharmaceutical preparations for the treatment of chronic diseases, namely, alpha-1 antitrypsin deficiency, moderate to severe persistent asthma, pulmonary arterial hypertension, respiratory syncytial virus, chronic, moderate to severe plaque psoriasis, hereditary tyrosinemia type 1, autoimmune disorders and primary immune deficiencies, growth hormone deficiency, Fabry disease, rheumatoid arthritis, psoriatic arthritis, hemophilia, Gaucher disease, blepharospasm, cervical dystonia, hyperhidrosis, strabimus, multiple sclerosis, hypomobility associated with advanced Parkinson's disease, MPS 1, severe combined immunodeficiency disease, chronic granulomatour disease, severe malignant osterpetrosis; pharmaceutical preparations for use as blood clotting agents used in the control of hemophilia;Retail pharmacy services specializing in the control of chronic diseases; retail pharmacy services specializing in the control of hemophilia;Nursing care specializing in the treatment, prevention and control of chronic diseases; nursing care specializing in the treatment, prevention and control of hemophilia; medical services, namely, administration of pharmaceutical preparations used in the treatment of chronic diseases and administration of pharmaceutical preparations used in the treatment of hemophilia;HEALTH GROUP;

ACCREDO HEALTH GROUP, INC.

Pharmaceutical preparations for the treatment of chronic diseases, namely, alpha-1 antitrypsin deficiency, moderate to severe persistent asthma, pulmonary arterial hypertension, respiratory syncytial virus, chronic, moderate to severe plaque psoriasis, hereditary tyrosinemia type 1, autoimmune disorders and primary immune deficiencies, growth hormone deficiency, Fabry disease, rheumatoid arthritis, psoriatic arthritis, hemophilia, Gaucher disease, blepharospasm, cervical dystonia, hyperhidrosis, strabimus, multiple sclerosis, hypomobility associated with advanced Parkinson's disease, MPS 1, severe combined immunodeficiency disease, chronic granulomatour disease, severe malignant osterpetrosis; pharmaceutical preparations for use as blood clotting agents used in the control of hemophilia;Color is not claimed as a feature of the mark.;Retail pharmacy services specializing in the control of chronic diseases; retail pharmacy services specializing in the control of hemophilia;Nursing care specializing in the treatment, prevention and control of chronic diseases; nursing care specializing in the treatment, prevention and control of hemophilia; medical services, namely, administration of pharmaceutical preparations used in the treatment of chronic diseases and administration of pharmaceutical preparations used in the treatment of hemophilia;HEALTH GROUP, INC.;

ACCREDO NOVA FACTOR BIOPHARMACEUTICAL SERVICES

Retail pharmacy services specializing in the treatment and control of chronic diseases;Nursing care specializing in the treatment, prevention and control of chronic diseases;BIOPHARMACEUTICAL SERVICES;

BLOODSTONE MAGAZINE

printed publications, namely, magazines featuring articles and information on blood disorders;MAGAZINE;

CHEMODIRECT

Distribution services, namely, delivery of patient-specific medications to customers as part of an oncology practice support program;CHEMO DIRECT;Health care services, namely, providing an oncology support program focused primarily at supporting oncology practices, namely, providing pharmaceutical consultation in the field of oncology; dispensing pharmaceuticals, namely, providing an oncology support program focused on supporting oncology practices by dispensing patient-specific medication;Oncology support program focused on supporting oncology, namely, consultancy pertaining to pharmacology in the field of oncology;

CLINICAL BUSINESS SOLUTIONS A DIVISION OF ACCREDO HEALTH GROUP

Providing patient educational services, namely, conducting programs in the field of chronic disease, proper product-reconstitution and administration, and resources appropriate for support of disease management; educational services for product manufacturers, pharmaceutical clinicians and biotech companies, clinicians, contract research organizations and insurance providers, namely, conducting classes, one-on-one sessions and telephonic workshops in the field of clinical education and distributing course materials in connection therewith; educational services, namely, classes, one on one sessions and telephonic workshops which provide physicians, insurance companies and patients with specific characteristics associated with disease management products;CLINICAL BUSINESS SOLUTIONS and DIVISION and HEALTH GROUP;Providing clinical research in the field of medicine for product manufacturers, pharmaceutical and biotech companies, contract research organizations and insurance providers, and providing consulting services in support of new drug product launches;

EFACTORCARE

ELECTRONIC FACTOR CARE;providing information concerning medical care and treatment in the field of hemophilia via the internet;E;

KARING FOR KIDS INNOVATIVE LEARNING

educational services, namely, conducting workshops for children to help them understand hemophilia;The mark consists of KARING FOR KIDS in stylizd font in front of an oval background with the k in KIDS appearing backwards and the words INNOVATIVE LEARNING in a banner design below.;CARING FOR KIDS INNOVATIVE LEARNING;Color is not claimed as a feature of the mark.;Telephone hotline counseling, namely offering healthcare advice regarding bleeding disorders;

MIND THE GAP

The mark consists of a circle shape with a horizontal line through the center that has the phrase MIND THE GAP.;Color is not claimed as a feature of the mark.;Providing services to patients with rare chronic diseases, namely, retail pharmacy services specializing in the control of bleeding disorders including hemophilia and von Willebrand disease;Providing nursing care services specializing in the treatment and control of bleeding disorders, including hemophilia and von Willebrand disease;